Filing metadata

Accession number
0000950170-23-066136
Form type
Form 3
Filer
Spyre Therapeutics, Inc.
CIK
CIK 1636282
Filed
Nov 27, 2023
Reporting period
Nov 22, 2023
Description
Initial ownership

Explore SEC Filings Hub